Literature DB >> 12667945

Drug- and mutagenesis-induced changes in the selectivity filter of a cardiac two-pore background K+ channel.

Péter Hajdú1, Chris Ulens, György Panyi, Jan Tytgat.   

Abstract

OBJECTIVE: As compared with voltage-gated K(+) channels (Kv-type), our knowledge of the structure-function and pharmacology of two-pore background K(+) channels is still very limited. Here we have used a drug- and mutagenesis-based approach to study the effect of the antidepressant fluoxetine (FL) and analgesic D-norpropoxyphene (NORP) on the cardiac two-pore background K(+) channel.
METHODS: Whole-cell currents of the cTBAK-1 channel expressed in Xenopus laevis oocytes were investigated using conventional two-microelectrode voltage-clamp recording method combined with functional mutagenesis of the channel protein.
RESULTS: Both drugs inhibit cTBAK-1 current: FL proved to be a voltage-dependent pore-blocker, while NORP induced a change in the selectivity of cTBAK-1 giving rise to a shift in the reversal potential (E(rev)) toward more positive voltages due to an increased Na(+) permeability. Mutations were introduced into the selectivity filter of the first (Y105F) and the second (F211Y) pore to mimic the P-region of HERG (GFGN) and Kv1.1 (GYGD) channels. Point mutations in the channel resulted in two distinct phenotypes of cTBAK-1: the mutant Y105F channel lost its selectivity and was unaffected by NORP, in contrast to the F211Y mutant.
CONCLUSION: FL and NORP block the current of cTBAK-1 channels differently, the latter modified the selectivity of the channel pore. Our mutagenesis study revealed that NORP interacts with the selectivity filter of cTBAK-1. The significant role of the GYGD motif in this type of K(+) channels is emphasized.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667945     DOI: 10.1016/s0008-6363(02)00831-3

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  5 in total

1.  Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine.

Authors:  Louise E Kennard; Justin R Chumbley; Kishani M Ranatunga; Stephanie J Armstrong; Emma L Veale; Alistair Mathie
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

Review 2.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

3.  Activation of TREK currents by riluzole in three subgroups of cultured mouse nodose ganglion neurons.

Authors:  Diego Fernández-Fernández; Alba Cadaveira-Mosquera; Lola Rueda-Ruzafa; Salvador Herrera-Pérez; Emma L Veale; Antonio Reboreda; Alistair Mathie; J Antonio Lamas
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

4.  Developmental expression of a functional TASK-1 2P domain K+ channel in embryonic chick heart.

Authors:  Hengtao Zhang; Jeremy Parker; Neal Shepherd; Tony L Creazzo
Journal:  J Biomed Sci       Date:  2009-11-23       Impact factor: 8.410

5.  The selectivity, voltage-dependence and acid sensitivity of the tandem pore potassium channel TASK-1: contributions of the pore domains.

Authors:  K H Yuill; P J Stansfeld; I Ashmole; M J Sutcliffe; P R Stanfield
Journal:  Pflugers Arch       Date:  2007-06-01       Impact factor: 3.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.